Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the HSD11B2 gene (encoding human 11beta-hydroxysteroid dehydrogenase type 2) explain the syndrome of apparent mineralocorticoid excess where cortisol acts as a mineralocorticoid.
|
11916625 |
2002 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Genetic analysis of the HSD11B2 gene from the AME patients revealed the homozygous deletion of six nucleotides in exon 2 with the resultant loss of amino acids Leu(114) and Glu(115), representing the first alteration found in the cofactor-binding domain.
|
11238516 |
2001 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The HSD11B2 (HSD11K) gene encoding the kidney isozyme of 11beta-hydroxysteroid dehydrogenase is mutated in the syndrome of apparent mineralocorticoid excess, an autosomal recessive form of salt-sensitive hypertension.
|
11531933 |
2001 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Genetic analysis of the HSD11B2 gene from the AME patients revealed the homozygous deletion of six nucleotides in exon 2 with the resultant loss of amino acids Leu(114) and Glu(115), representing the first alteration found in the cofactor-binding domain.
|
11238516 |
2001 |
Apparent mineralocorticoid excess
|
0.800 |
Biomarker
|
disease |
CTD_human |
Dexamethasone-suppressible hypertension.
|
11085685 |
2000 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the HSD11B2 gene encoding the kidney (11-HSD2) isozyme of 11beta-hydroxysteroid dehydrogenase cause the syndrome of apparent mineralocorticoid excess, a form of salt-sensitive hypertension.
|
11196453 |
2000 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Apparent mineralocorticoid excess (AME) syndrome is a rare inherited disorder caused by 11beta-hydroxysteroid dehydrogenase (11-HSD 2) isozyme deficiency in the kidney.
|
11095013 |
2000 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the HSD11B2 gene cause a rare monogenic juvenile hypertensive syndrome called apparent mineralocorticoid excess (AME).
|
10760070 |
2000 |
Apparent mineralocorticoid excess
|
0.800 |
Biomarker
|
disease |
BEFREE |
Whereas the first patients described with AME had a severe form of hypertension and metabolic derangements, with an increased urinary ratio of cortisol (THF+5alphaTHF) to cortisone (THE) metabolites, more subtle effects of mild 11 beta HSD2 deficiency on blood pressure have recently been observed.
|
10726708 |
2000 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the HSD11B2 gene encoding the kidney (11-HSD2) isozyme of 11beta-hydroxysteroid dehydrogenase cause apparent mineralocorticoid excess, a form of familial hypertension.
|
10948076 |
2000 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Genetic, biochemical, and clinical studies of patients with A328V or R213C mutations in 11betaHSD2 causing apparent mineralocorticoid excess.
|
10489390 |
1999 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Mutants of 11beta-hydroxysteroid dehydrogenase (11-HSD2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess.
|
10523339 |
1999 |
Apparent mineralocorticoid excess
|
0.800 |
Biomarker
|
disease |
BEFREE |
The patient came from an inbred Mennonite family, and though the mutation identified her as an AME patient, she had a normal birth weight and did not demonstrate the typical features of AME, such as hypokalemic alkalosis, low birth weight, failure to thrive, poor growth, and in many cases nephrocalcinosis.
|
10599743 |
1999 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutants of 11beta-hydroxysteroid dehydrogenase (11-HSD2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess.
|
10523339 |
1999 |
Apparent mineralocorticoid excess
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutants of 11beta-hydroxysteroid dehydrogenase (11-HSD2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess.
|
10523339 |
1999 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
The codon 213 of the 11beta-hydroxysteroid dehydrogenase type 2 gene is a hot spot for mutations in apparent mineralocorticoid excess.
|
9851783 |
1998 |
Apparent mineralocorticoid excess
|
0.800 |
Biomarker
|
disease |
CTD_human |
Typical patients with AME have defective 11beta-HSD2 activity, as evidenced by an abnormal ratio of cortisol to cortisone metabolites and by an exceedingly diminished ability to convert [11-3H]cortisol to cortisone.
|
9707624 |
1998 |
Apparent mineralocorticoid excess
|
0.800 |
Biomarker
|
disease |
CTD_human |
In the apparent mineral corticoid excess (AME) syndrome type 1, absence of 11 beta-HSD2 activity is caused by mutations in the gene coding for 11 beta-HSD2.
|
9683905 |
1998 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In 1995, it was shown that mutations in the gene (HSD11B2) encoding the 11beta-hydroxysteroid dehydrogenase type 2 enzyme (11beta-HSD2) cause AME.
|
9707624 |
1998 |
Apparent mineralocorticoid excess
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Apparent mineralocorticoid excess (AME) is a genetic disorder causing pre- and postnatal growth failure, juvenile hypertension, hypokalemic metabolic alkalosis, and hyporeninemic hypoaldosteronism due to a deficiency of 11 beta-hydroxysteroid dehydrogenase type 2 enzyme activity (11 beta HSD2).
|
9661590 |
1998 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Apparent mineralocorticoid excess (AME) is a genetic disorder causing pre- and postnatal growth failure, juvenile hypertension, hypokalemic metabolic alkalosis, and hyporeninemic hypoaldosteronism due to a deficiency of 11 beta-hydroxysteroid dehydrogenase type 2 enzyme activity (11 beta HSD2).
|
9661590 |
1998 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
"Molecular basis for hypertension in the ""type II variant"" of apparent mineralocorticoid excess."
|
9683587 |
1998 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Together, these results indicate that this patient is a compound heterozygote for the mutation in the 11 beta HSD2 gene (R208H and R337H, delta Y338) and that these mutations inactivate the 11 beta HSD2 function and give rise to clinically manifest AME.
|
9398712 |
1997 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Homozygous mutations in 11beta-HSD2 gene in patients with AME have been described.
|
9431844 |
1997 |
Apparent mineralocorticoid excess
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations generating inactive enzymes have been described in the HSD11B2 gene in the congenital syndrome of apparent mineralocorticoid excess (AME)--a low renin form of hypertension.
|
9247735 |
1997 |